Navigation Links
US Oncology Celebrates Consecutive Safety
Date:12/3/2009

HOUSTON, Dec. 3 /PRNewswire/ -- Three US Oncology, Inc. businesses received a Safety Excellence Perfect Record Award in the Occupational Safety & Health category from the National Safety Council. Since inception in 2005, US Oncology Specialty, LP; US Oncology Clinical & Research Pharmacy distribution center; and OncologyRx Care Advantage(TM) oral oncology pharmacy have continuously received the Occupational Excellence Award from the national organization, making this the third year the US Oncology businesses have been awarded. More information can be found at www.usoncology.com.

"We are very proud of our continuous safety record," says Rolando DeCardenas, vice president and general manager of the three US Oncology companies. "It is very difficult in the distribution business to go through a year of no accidents. To be able to achieve this continuously since inception, and for all three businesses, speaks volumes about the safety initiatives we have in place. The managers and leaders of the business units, our Compliance team, and the associates have done a great job of eliminating workplace accidents. We are very proud of this accomplishment."

The award is presented to companies, units and/or facilities that have completed a period of at least 12 consecutive months without incurring an occupational injury or illness that resulted in days away from work or death.

From 2008 to 2009, US Oncology Specialty, OncologyRx Care Advantage, and US Oncology Clinical & Research Pharmacy distribution center each achieved a zero percent incidence rate for number of days away from work. Following are the 2009 statistics for each:

  • US Oncology Specialty, LP - 34 employees who worked 63,628 hours
  • OncologyRx Care Advantage--25 employees working 47,765 hours
  • US Oncology Clinical & Research Pharmacy distribution center --16 employees who worked 29,989 hours

Formed in 1999, US Oncology works with physicians, payers, and manufacturers to offer advanced cancer care to patients in America. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology Specialty, LP, is US Oncology's VAWD(TM) certified drug distribution center focused on delivering safe and effective oncology drugs to community-based practices. Its ePedigree technology tracks all products from manufacturer to the practice, and back again in case of returns.

OncologyRx Care Advantage, a national oral oncology pharmacy, provides patients with convenient home delivery of oral cancer therapies and the additional support necessary for safe and supervised use of these oral therapy treatments. Last year the specialty pharmacy successfully expanded to a national service offering, bringing access to home delivery of oral drugs and critical patient support to cancer patients in all 50 U.S. states and the territory of Puerto Rico.

US Oncology Clinical & Research Pharmacy distribution center distributes investigational drug products related to clinical research to oncology practices involved in US Oncology Research.

About US Oncology

US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,310 physicians operating in 493 locations, including 98 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.

About the National Safety Council

The National Safety Council saves lives by preventing injuries and deaths at work, in homes and communities, and on the roads, through leadership, research, education and advocacy.

SOURCE US Oncology, Inc.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology: